drugset
drugset / Trial / NCT07259564

A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)

NCT07259564 ↗

Phase 2 Terminated 120 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelOther

Summary

The GS3-007a Growth Hormone Stimulation Test (GHST) will be compared with the Insulin Tolerance Test (ITT) in an open-label, randomized, three-way crossover trial. The trial will include subjects suspected to have adult growth hormone deficiency (AGHD) and a group of healthy control subjects.

Timeline

Start
2025-12-19
Primary completion
2026-04-15
Completion
2026-05-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GS3-007a Unknown — Oral
Subject Insulin Protein / enzyme biologic 0.1 iu/kg Intravenous
Subject Insulin Protein / enzyme biologic 0.15 iu/kg Intravenous

Indications

pituitary deficiency